Acute Coronary Syndrome  >>  icosapent ethyl  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
icosapent ethyl / Generic mfg.
EVAPORATE, NCT02926027: Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy

Completed
4
80
US
Vascepa, icosapent ethyl, placebo
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Intermountain Research and Medical Foundation
Hypertriglyceridemia
05/20
08/20

Download Options